RxDoctor Payments Data

Ashby Johnston

Surgical · Danville, INNPI 1225786262

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,278 of the $2,016 with a category attached, or 63.4%. 13 manufacturers reported payments, led by Atricure, Inc. at 57.9% of the total. Reporting peaked in 2023 at $1,302 and has fallen 60.5% since, to $514 in 2025.

$2,016in general payments, 2019–2025

Across 33 payments — averaging $61.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$1K
  • Edwards Lifesciences$210
  • Boston Scientific$161
  • Biotronik Inc.$130
  • Medical Device Business Services, Inc.$117
  • Novo Nordisk$47
  • plus $184 from 7 others

What the payments were for

  • Travel & lodging$72036%
  • Food & beverage$1,27863%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,016 in reported general payments places this provider in the 85th percentile of 130 surgical providers in Indiana.

See all surgical providers in Indiana

Medicare billing

Part B allowed, 2024
$4,939
Medicare patients
63
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amiodarone Hcl17$149
ClopidogrelClopidogrel Bisulfate23$133
Potassium Chloride27$87
Metoprolol Tartrate20$41
Furosemide31$32

Paid to pharmacies, not to this prescriber.

Other surgical in Danville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →